Olainfarm Overview
- Founded
-
1972

- Status
-
Public
- Employees
-
2,191

- Investments
-
10
- Share Price
-
$9.89
- (As of Monday Closing)
Olainfarm General Information
Description
AS Olainfarm is a pharmaceutical company. It is engaged in the manufacturing of finished drug forms and chemical-pharmaceutical products in the Baltics. The group operates its activities through Medicine Production segment, Wholesale segment, Retail segment, Compression Materials segment and Other segments. Olainfarm Group exports to more than 60 countries worldwide and its main export markets are Russia, Belarus, Ukraine, The Netherlands, Kazakhstan, Uzbekistan, and Germany. Farthest export market - Australia.
Contact Information
Website
lv.olainfarm.com
Formerly Known As
Olaines Kīmiski-Farmaceitiskā Rūpnīca
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Former Stock Listing
UU4
Primary Office
- 5 Rupnicu Street
- Olaine, LV-2114
- Latvia
+371 67 000 000
Olainfarm Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$9.89 | $10.04 | $8.16 - $10.85 | $148M | 14.1M | $1.21 |
Olainfarm Financials Summary
In Thousands, USD |
TTM 30-Sep-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
---|---|---|---|---|
EV | 137,380 | 112,427 | 128,756 | |
Revenue | 158,182 | 139,248 | 153,609 | 146,630 |
EBITDA | 21,853 | 22,359 | 35,971 | 21,924 |
Net Income | 17,119 | 10,804 | 24,922 | 12,663 |
Total Assets | 207,364 | 211,139 | 188,939 | 169,196 |
Total Debt | 9,330 | 22,331 | 24,358 | 28,631 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Olainfarm Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Olainfarm Patents
Olainfarm Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2010502577-A | Method for producing 3- (2,2,2-trimethylhydrazinium) propionate dihydrate | Active | 04-Sep-2006 | 00000000 | |
JP-5214608-B2 | Method for producing 3- (2,2,2-trimethylhydrazinium) propionate dihydrate | Inactive | 04-Sep-2006 | 00000000 | |
US-8153842-B2 | Method for producing 3-(2,2,2-trimethyl-hydrazinium) propionate dihydrate | Inactive | 04-Sep-2006 | 00000000 | |
CA-2661357-C | Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate | Inactive | 04-Sep-2006 | 00000000 | |
CA-2661357-A1 | Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate | Active | 04-Sep-2006 | C07C1/26 |
Olainfarm Executive Team (6)
Olainfarm Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
00000 00000000 | Olainfarm | Chief Executive Officer & Board Member | 000 0000 |
00000000 000000000 | Olainfarm | Board Member & Director of the Quality Management Department | 000 0000 |
000000000 00č00000 | Olainfarm | Director of Business Development & Board Member | 000 0000 |
Olainfarm Signals
Olainfarm Investments & Acquisitions (10)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 00000 | 21-Jun-2017 | 0000000000 | 00000 | Clinics/Outpatient Services | 000000000 |
000000 000000 | 10-Nov-2016 | 0000000000 | Clinics/Outpatient Services | ||
000 0000000 | 08-Sep-2016 | 000000000 | Drug Discovery | ||
00000 00000 | 12-May-2016 | 0000000000 | 000.00 | Medical Supplies | |
Kiwi Cosmetics | 20-Jan-2016 | Merger/Acquisition | Personal Products |
Olainfarm Subsidiaries (5)
Company Name | Industry | Location | Founded |
---|---|---|---|
Kiwi Cosmetics | Personal Products | Jelgava, Latvia | 2011 |
000000 000000 | Clinics/Outpatient Services | Riga, Latvia | 0000 |
00000 00000 | Medical Supplies | Nicas Novads, Latvia | 0000 |
000000000 | Pharmaceuticals | Riga, Latvia | 0000 |
0000000 00000ī000 | Clinics/Outpatient Services | Olaine, Latvia | 0000 |